- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Page 317
Renmatix processes $14m in Total-backed round
The biomass-to-biofuel technology developer has secured $14m from Total and Bill Gates, weeks after a securities filing indicated it would raise $31m.
Sep 20, 2016Rakuten recognises ViSenze in series B round
Rakuten Ventures has co-led a $10.5m round for visual technology producer ViSenze, having also led its $3.5m series A two and a half years ago.
Sep 20, 2016KeyMe locks in $15m
Comcast and 7-Eleven have both returned to back a series C round for KeyMe, which has created technology to quickly duplicate digital automotive keys.
Sep 19, 2016Eyevensys spies $10m series A close
The ophthalmic disease treatment developer has closed its series A round, which included Boehringer Ingelheim's corporate venturing unit.
Sep 16, 2016Eyevensys re-inspects series A
Eyevensys, based on reserach conducted at Paris Descartes University, closes its series A round at $10m three years after it raised the initial tranche.
Sep 16, 2016Time Warner tunes into You.i TV
Time Warner has contributed to a $12m round for video app technology developer You.i TV through its corporate venturing subsidiary.
Sep 16, 2016Westpac proves the one for Uno
Westpac has put money into a $16.5m funding round for digital mortgage broker Uno, which comes four months after the company was launched.
Sep 16, 2016Nykaa plays nice with $12m round
TVS Capital Funds reinvested as part of a round that doubled the beauty e-commerce platform's funding to more than $24.5m.
Sep 14, 2016Sarcos brings corporates on board in $10.5m round
The robotics technology developer raised the funding in a round featuring strategic investors General Electric, Caterpillar and Microsoft.
Sep 14, 2016Novartis enters Inflazome in $17m series A
Novartis has co-led a $17m series A round for Inflazome, which is working on treatments for a range of chronic inflammatory diseases.
Sep 13, 2016About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


